MedPath

Sentinel Node and Endometrial Cancer

Not Applicable
Completed
Conditions
Endometrial Neoplasms
Interventions
Procedure: Detection of sentinel node
Registration Number
NCT00987051
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The purpose of this study is to investigate the relevance of sentinel node in endometrial cancer. Sentinel node is thought to reflect the status of lymph node. Only 10 to 20% of women with endometrial cancer exhibit lymph node metastasis hence systematic lymphadenectomy is questionable. In breast cancer, melanoma and vulvar cancer, sentinel node has emerged as an alternative to complete lymphadenectomy.

Detailed Description

To investigate the relevance of sentinel node in endometrial cancer. Sentinel node is though to reflect the status of lymph node. Only 10 to 20% of women with endometrial cancer exhibit lymph node metastasis hence systematic lymphadenectomy is questionable. In breast cancer, melanoma and vulvar cancer, sentinel node has emerged as an alternative to complete lymphadenectomy. The objective of our trial is to validate the concept of sentinel node in endometrial cancer.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
133
Inclusion Criteria
  • patient over 18 years old with a surgery planned for endometrial cancer
  • endometrial cancer proved by biopsy
  • early stage of endometrial cancer (FIGO stage 1-2)
  • without contraindication to surgery
  • inform consent signed
  • affiliated to general health system
Read More
Exclusion Criteria
  • endometrial cancer FIGO stages 3-4
  • previous history of surgery modifying lymphatic drainage (conization myomectomy)
  • pregnant women or breast feeding
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Detection of sentinel nodePatients with endometrial cancer
Primary Outcome Measures
NameTimeMethod
Detection and false negative rates of sentinel nodeDuring the surgery (hysterectomy)
Secondary Outcome Measures
NameTimeMethod
Morbidity and recurrence ratesDuring 24 months

Trial Locations

Locations (1)

Tenon Hospital

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath